Reported Aug 25, 2021 · Terminated

Octreotide Acetate Injection 1000 mcg/5mL, 5 mL multi-dose vial, Rx only, Teva Pharmaceuticals USA. Inc. North Wales,…

Teva Pharmaceuticals USA

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Teva Pharmaceuticals USA · 400 Interpace Pkwy · Parsippany, NJ · 07054-1120

Is this the product you have?

    • Octreotide Acetate Injection 1000 mcg/5mL
    • 5 mL multi-dose vial
    • Rx only
    • Teva Pharmaceuticals USA. Inc. North Wales
    • PA 19454
    • NDC 0703-3333-01
Lot codes and dates
    • Lot #: 31329150B
    • exp. date 06/2022
Amount recalled
16,644 vials

This recall covers 19 products

The agency filed one notice per product. You are reading one of them; the other 18 are below.

6 more are in the archive.

Where it was sold

  • Nationwide
  • PR

Why it was recalled

Lack of Assurance of Sterility

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Teva Pharmaceuticals USA recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Jun 4, 2024 · Data as of Sep 19, 8:06 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.